Skip to main content

Nonprofit · EIN 83-2886283

ADVANCING CANCER TREATMENT

Tax-exempt · MOULTONBORO, NH 03254

Financials

$2.1M$1.3M2023$43K$824K2024
Revenue Expenses · by fiscal year end
Financials of ADVANCING CANCER TREATMENT by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$43,476$824,363-$780,887$714,351$34,948$679,403
December 31, 2023990$2,068,192$1,260,009$808,183$1,484,614$29,884$1,454,730
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$0
Program service revenue
$0
Investment income
$43,476
Other revenue
$0

Expenses

Grants and similar amounts paid
$348,330
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Legal fees
$442
Accounting fees
$20,138
Program services (functional)
$785,629
Management and general (functional)
$37,222
Fundraising (functional)
$1,512

Balance sheet and other

Total assets, start of year
$1,484,614
Total assets, end of year
$714,351
Total liabilities, end of year
$34,948
Net assets, end of year
$679,403
Net assets without donor restrictions
$679,403
Gross receipts
$43,476
Employees
0
Volunteers
7
Year formed
2018
State of legal domicile
NH

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
OTIS W BRAWLEY MDDIRECTOR
Trustee or director
0.2$0
ROBERT L GROSSMANDIRECTOR
Trustee or director
0.2$0
JEANNY B ARAGON-CHING MDDIRECTOR
Trustee or director
0.2$0
DONALD L TRUMP MDDIRECTOR
Trustee or director
0.2$0
ADAM R METWALLI MDDIRECTOR
Trustee or director
0.2$0
PAMELA BROWNVICE PRESIDENT, SECRETARY
Trustee or director, Officer
0.2$0
DAVID BROWNPRESIDENT, TREASURER
Trustee or director, Officer
0.2$0
990 for the year ended December 31, 2023: 7 people
NameTitleHours / weekCompensation
OTIS BRAWLEYDIRECTOR
Trustee or director
0.2$0
ROBERT GROSSMANDIRECTOR
Trustee or director
0.2$0
JENNY B ARAGON-CHING MDDIRECTOR
Trustee or director
0.2$0
DONALD L TRUMP MDDIRECTOR
Trustee or director
0.2$0
ADAM R METWALLI MDDIRECTOR
Trustee or director
0.2$0
PAMELA BROWNVICE PRESIDENT, SECRETARY
Trustee or director, Officer
0.2$0
DAVID BROWNPRESIDENT, TREASURER
Trustee or director, Officer
0.2$0

Address and contacts

Address (IRS master file)
42 RUPPERT RD, MOULTONBORO, NH 03254-4624
Mailing address (990-N for 2018)
42 RUPPERT RD, MOULTONBOROUGH NH 03254
Principal officer (990 for 2024)
PAMELA BROWN, 42 RUPPERT RD, MOULTONBOROUGH, NH 03254
Principal officer (990-N for 2018)
PAM BROWN, 42 RUPPERT RD, MOULTONBOROUGH NH 03254
Signed the 990
PAMELA BROWN, VICE PRESIDENT, SECRETARY
Phone
(972) 935-6510
Return prepared by
Hendershot Burkhardt Tax Services Inc

Mission

ACTS MISSION IS TO MAKE THE WASHINGTON, DC METROPOLITAN AREA A LEADER IN ADVANCING CLINICAL TRIAL ACCRUAL, THUS ACCELERATING IMPROVED CANCER CARE AND TREATMENT.

990 for the year ended December 31, 2024

Program accomplishments

  • ACTS CURRENT FOCUS IS IMPROVING ACCRUAL TO PROSTATE CANCER CLINICAL TRIALS. ACTS GOAL IS TO CREATE A PROSTATE REGISTRY AIMED AT GETTING A SIGNIFICANT PORTION OF PROSTATE CANCER PATIENTS TO SIGN UP TO PARTICIPATE BY SUBMITTING A SIMPLE SALIVA TEST THAT WILL PROVIDE THEIR GENETIC INFORMATION FOR RESEARCH, AND PROVIDE AN ALERT SERVICE TO THEM IF ANY TREATMENTS OR THERAPIES MATCH THEIR PROFILE AND COULD HELP CHANGE THEIR OUTCOME.
    Expenses $785,629 · grants $348,330

What it must file and when

IRS records say it files Form 990-N (e-Postcard). Gross receipts normally $50,000 or less. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
83-2886283
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2019
Accounting year ends
December
Files
Form 990-N (e-Postcard)
Assets (IRS master file)
$714,351
Income (IRS master file)
$43,476

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$43,476$824,363$714,351XML
990December 2023$2,068,192$1,260,009$1,484,614XML
990December 2022$3,010,183$3,103,502$683,975IRS
990December 2021–––IRS
990December 2020–––IRS
990-N for 2018
Officer: PAM BROWN
December 31, 2018≤ $50,000 receipts––e-Postcard

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 83-2886283).

Questions about ADVANCING CANCER TREATMENT

What is the EIN of ADVANCING CANCER TREATMENT?
The employer identification number (EIN) of ADVANCING CANCER TREATMENT is 83-2886283.
Is ADVANCING CANCER TREATMENT tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2019.
Are donations to ADVANCING CANCER TREATMENT tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does ADVANCING CANCER TREATMENT file?
Form 990-N (e-Postcard). Gross receipts normally $50,000 or less.
When is the next return of ADVANCING CANCER TREATMENT due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did ADVANCING CANCER TREATMENT last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of ADVANCING CANCER TREATMENT?
The 990 for the year ended December 31, 2024 names PAMELA BROWN.
Who are the officers and directors of ADVANCING CANCER TREATMENT?
The 990 for the year ended December 31, 2024 lists 7 people; 0 received compensation from the organization.
How much revenue does ADVANCING CANCER TREATMENT have?
On its 990 for the year ended December 31, 2024 it reported revenue of $43,476, expenses of $824,363 and total assets of $714,351 at year end.

Other nonprofits in MOULTONBORO

All nonprofits in MOULTONBORO · New Hampshire · Voluntary health associations and medical disciplines